Legal Opinion
Sanofi-Aventis Deutschland GmbH v. Genentech, Inc.
District Court, E.D. Texas
Decided March 19, 2009No. 1:08-cv-00203PublishedCited by 5 opinions
1Opinion of the Court
ORDER DENYING DEFENDANTS’ MOTION TO CHANGE VENUE
RON CLARK, District Judge.
Plaintiff Sanofi-Aventis Deutschland GmbH (“Sanofi”) filed suit against Defendants Genentech, Inc. and Biogen Idee Inc., claiming that nine of Genentech’s biotherapeutics infringe United States Patent Nos. 5,849,522 and 6,218,140. Both of the patents are directed toward nucleic acid enhancers for cellular expression systems that can be used to produce drugs or antibodies for human therapy. Genentech now moves to transfer venue to the United States District Court for the Northern District of California, alleging that one…
2Cases cited16 opinions
- Van Dusen v. BarrackSupreme Court of the United States · 1964
- In re Volkswagen of America, Inc.Court of Appeals for the Fifth Circuit · 2008
- In Re Volkswagen Ag Volkswagen of America, Inc.Court of Appeals for the Fifth Circuit · 2004
- Time, Inc. v. Frank ManningCourt of Appeals for the Fifth Circuit · 1966
- In Re TS Tech USA Corp.Court of Appeals for the Federal Circuit · 2008
11 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- B.E. Technology, LLC v. Facebook, Inc.District Court, W.D. Tennessee · 2013
- Sanofi-Aventis Deutschland GmbH v. Noyo Nordisk, Inc.District Court, E.D. Texas · 2009
- B.E. Technology, LLC v. Groupon, Inc.District Court, W.D. Tennessee · 2013
- In Re Genentech, Inc.Court of Appeals for the Federal Circuit · 2009
- Rampart IC, LLC v. Egg Medical, Inc.District Court, D. Delaware · 2025